Lung Non-Small Cell Squamous Carcinoma — Trials

Lung Non-Small Cell Squamous Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 47%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05652868	Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer	terminated	Phase 1	227	Mythic TherapeuticsINDUSTRY	7	Dec 16, 2025	clinicaltrials
NCT04032704	A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors	terminated	Phase 2	205	Seagen Inc.INDUSTRY	6	Mar 10, 2025	clinicaltrials